WS #11254
Drugmakers traded higher after Trump administration proposed reducing payment rates under the 340B drug discount program.
Big Pharma Gains on 340B Discount Cut Proposal
Drugmakers traded higher after Trump administration proposed reducing payment rates under the 340B drug discount program.